Builders FirstSource Reports Significant Q4 & Full-Year 2025 Declines, Provides Cautious 2026 Outlook
summarizeSummary
Builders FirstSource reported significant year-over-year declines in Q4 and full-year 2025 net sales, net income, and Adjusted EBITDA, attributing the weakness to a challenging housing market, and provided a cautious 2026 financial outlook.
check_boxKey Events
-
Q4 2025 Financial Performance
Net sales decreased 12.1% to $3.4 billion, and diluted EPS fell 83.4% to $0.28 year-over-year, primarily due to a below-normal starts environment and lower gross profit.
-
Full-Year 2025 Results
Net sales declined 7.4% to $15.2 billion, and net income decreased 59.6% to $435.2 million, reflecting a challenging housing market and reduced operating leverage.
-
Adjusted EBITDA Declines
Q4 2025 Adjusted EBITDA decreased 44.3% to $274.9 million, and full-year Adjusted EBITDA was down 32.0% to $1.6 billion, driven by lower gross profit.
-
2026 Financial Outlook
The company projects 2026 net sales in the range of $14.8 billion to $15.8 billion and Adjusted EBITDA between $1.3 billion and $1.7 billion, indicating a cautious and potentially flat market environment.
auto_awesomeAnalysis
Builders FirstSource experienced substantial financial deterioration in 2025, with fourth-quarter net income plummeting 83.4% and full-year net income down 59.6%. This was primarily driven by a challenging housing market, a 'below-normal starts environment,' commodity deflation, and reduced operating leverage. While management emphasized disciplined execution and strategic investments, the 2026 outlook suggests continued headwinds, with net sales and Adjusted EBITDA projected to be relatively flat compared to 2025. Investors should closely monitor the company's ability to realize anticipated productivity savings and navigate the persistent challenges in the housing market to stabilize profitability.
At the time of this filing, BLDR was trading at $114.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $12.7B. The 52-week trading range was $94.35 to $157.96. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.